Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Himalaya aims to bulk...

    Himalaya aims to bulk up distribution, double sales by 2020

    Meghna A SinghaniaWritten by Meghna A Singhania Published On 2016-04-10T12:55:34+05:30  |  Updated On 10 April 2016 12:55 PM IST
    Himalaya aims to bulk up distribution, double sales by 2020
    Mumbai: Herbal health and personal care firm Himalaya Drug Company is looking to bulk up its distribution network across verticals as it eyes doubling sales to Rs 4,000 crore by 2020.

    "We are bulking up our sales and distribution across verticals, and aim to increase our sales force to about 7,000 from 2,000 during this year," the company's Chief Executive Officer Philip Haydon told PTI.

    The firm is present in personal care, pharma, baby care, animal health and wellness segments.

    "In the pharma business, we are looking to be present in 200-plus outlets, from 160 currently, and aim to cover over 1.5 lakh doctors this year," he added.

    The company is also looking to double its sales force in baby care from 800 to over 1,500 personnel.

    The Bengaluru-headquartered company recently set up a new division to focus on non-prescription drugs in areas like immunity, joint care, women's health and vitality. It expects Rs 100 crore revenue from this division in the current fiscal.

    "We started the (wellness) division in December and are well within reach of our target to earn Rs 100 crore in turnover this year from wellness," Haydon said.

    The wellness market in the country is estimated at Rs 14,000-crore and is currently dominated by two categories --- cough and cold medicines and health drinks.

    Personal care has also evolved into a key business category for the company, with the segment contributing to over 40 per cent of the company's Rs 2,000 crore turnover, followed by pharmaceuticals (35 percent), baby care (13 per cent) and animal health and wellness.

    The company plans to use its existing network of doctors, chemists and pharmacies to promote its wellness range, besides being present in supermarkets and small retail outlets.

    According to Haydon, the company hopes to grow at a compound annual rate of 20-25 per cent till 2020.

    Personal care is growing at around 30 per cent while baby care segment growth stands at around 50 per cent.
    HimalayaPhilip Haydon

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok